Should we look beyond the interferon signature in chilblain-like lesions associated with COVID-19?

Pilkington, S M; Watson, R E B · Br J Dermatol · 2021

editorial · Level V

Where this comes from

Abstract

<b>Linked Article:</b> Frumholtz <i>et al</i>. <i>Br J Dermatol</i> 2021;<b>185</b>:1176–1185.

Medical subject headings